Abstract
Behavioral data are reviewed that give evidence for an indiscriminate involvement of brain catecholamines (CA), especially dopamine (DA), in nervefunction, regardless of the time elapsed from their synthesis. Critical analysis of biochemical and pharmacological studies shows that a clear-cut distribution of brain catecholamines in two compartments [‘newly synthesized’ (NS) and ‘main storage’] is not at all established, and moreover that there is no adequate proof that the difference in turnover rates attributed to these two supposed pools is due to a preferential extraneuronal release of NS-CA during nerve function rather than to a preferential (nonfunctional) intraneuronal deamination of NS-CA, or at least of NS-DA.
Similar content being viewed by others
References
Ahlenius, S., Andén, N.-E., Engel, J.: Restoration of locomotor activity in mice by low l-Dopa doses after suppression by alpha-methyltyrosine but not by reserpine. Brain Res. 62, 189–199 (1973)
Almgren, O., Lundborg, P.: Correlation of the recovery of the granular uptake-storage mechanism and the nerve impulse induced release of (3H)noradrenaline after reserpine. J. Pharm. Pharmacol. 23, 671–677 (1971)
Andén, N.-E., Corrodi, H., Fuxe, K.: Turnover studies using synthesis inhibition. In: Metabolism of amines in the brain, G. Hooper, ed., pp. 38–47. London: McMillan 1969
Besson, M. J., Cheramy, A., Glowinski, J.: Effects of amphetamine and desmethylimipramine on amines synthesis and release in central catecholamine-containing neurons. Eur. J. Pharmacol. 7, 111–114 (1969)
Chiueh, C. C., Moore, K. E.: d-Amphetamine-induced release of “newly synthesized” and “stored” dopamine from the caudate nucleus in vivo. J. Pharmacol. Exp. Ther. 192, 642–653 (1975)
Clarke, D. E., Sampath, S. S.: Studies on the functional role of intraneuronal monoamine oxidase. J. Pharmacol. Exp. Ther. 187, 539–549 (1973)
Costa, E.: Methods for measuring indolealkylamine and catecholamine turnover rate “in vivo”. In: Chemistry and brain development, pp. 157–174. London: Plenum Press 1971
Costa, E., Groppetti, A., Naimzada, M. K.: Effects of amphetamine on the turnover rate of brain catecholamines and motor activity. Br. J. Pharmacol. 44, 742–751 (1972)
Costa, E., Neff, N. H.: Isotopic and non-isotopic measurements of the rate of catecholamine biosynthesis. In: Biochemistry and pharmacology of the basal ganglia, E. Costa, L. J. Coté, and M. D. Yahr, eds., pp. 141–155. New York: Raven Press 1966
Dahlström, A.: Aminergic transmission. Introduction and short review. Brain Res. 62, 441–460 (1973)
Deguchi, T., Axelrod, J.: Supersensitivity and subsensitivity of the beta-adrenergic receptor in pineal gland regulated by catecholamine transmitter. Proc. Natl. Acad. Sci. USA 70, 2411–2414 (1973)
Doteuchi, M., Wang, C., Costa, E.: Compartmentation of dopamine in rat striatum. Mol. Pharmacol. 10, 225–234 (1974)
Fibiger, H. C., Trimbach, C., Campbell, B. A.: Enhanced stimulant properties of (+)-amphetamine after chronic reserpine treatment in the rat: mediation by hypophagia and weight loss. Neuropharmacology 11, 57–67 (1972)
Fog, R.: On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats. Ph. D. dissertation in psychiatry, University of Copenhagen (Munksgaard, Copenhagen) 1972
Franklin, K. B. J., Herberg, L. J.: Self-stimulation and noradrenaline: evidence that inhibition of synthesis abolishes responding only if the “reserve” pool is dispersed first. Brain Res 97, 127–132 (1975)
Fuxe, K., Nyström, M., Tovi, M., Smith, R., Oegren, S.-O.: Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia. J. Psychiatr. Res. 11, 151–161 (1974)
Glowinski, J.: Some characteristics of the ‘functional’ and ‘main storage’ compartments in central catecholaminergic neurons. Brain Res. 62, 489–493 (1973)
Glowinski, J., Axelrod, J.: Effects of drugs on the disposition of 3H-norepinephrine in the rat brain. Pharmacol. Rev. 18, 775–785 (1966)
Häggendal, J., Lindqvist, M.: Disclosure of labile monoamine fractions in brain and their correlation to behavior. Acta Physiol. Scand. 60, 351–357 (1964)
Häggendal, J., Malmfors, T.: The effect of nerve stimulation on catecholamines taken up in adrenergic nerves after reserpine pretreatment. Acta Physiol. Scand. 75, 33–38 (1969)
Herz, A., Bläsig, J., Papeschi, R.: Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats. Psychopharmacologia (Berl.) 39, 121–143 (1974)
Javoy, F., Glowinski, J.: Dynamic characteristics of the ‘functional compartment’ of dopamine in dopaminergic terminals of the rat striatum. J. Neurochem. 18, 1305–1311 (1971)
Javoy, F., Hamon, M., Glowinski, J.: Disposition of newly synthesized amines in cell bodies and terminals of central catecholaminergic neurons. I. Effect of amphetamine and thioproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus. Eur. J. Pharmacol. 10, 178–188 (1970)
Khalsa, J. H., Davis, W. M.: Effects of a dopamine beta-hydroxylase inhibitor on amphetamine-induced hyperactivity in rats. J. Pharm. Pharmacol. 27, 620–622 (1975)
Kopin, I. J., Breese, G. R., Krauss, K. R., Weise, V. K.: Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. J. Pharmacol. Exp. Ther. 161, 271–278 (1968)
Korf, J., Roth, R. H., Aghajanian, G. K.: Alterations in turnover and endogenous levels of norepinephrine in cerebral cortex following electrical stimulation and acute axotomy of cerebral noradrenergic pathways. Eur. J. Pharmacol. 23, 276–286 (1973)
Marsden, C. A., Curzon, G.: Studies on the behavioral effects of tryptophan and p-chlorophenylalanine. Neuropharmacology 15, 165–171 (1976)
Moore, K. E., Dominic, J. A.: Tyrosine hydroxylase inhibitors. Fed. Proc. 30, 859–870 (1971)
Müller, R. A., Thönen, H., Axelrod, J.: Increase in tyrosine hydroxylase activity after reserpine administration. J. Pharmacol. Exp. Ther. 169, 74–79 (1969)
Papeschi, R.: Dopamine, extrapyramidal system and psychomotor function. Psychiatr. Neurol. Neurochir. (Amster.) 75, 13–48 (1972)
Papeschi, R.: Behavioral and biochemical interaction between AMT and (+)-amphetamine: relevance to the identification of the functional pool of brain catecholamines. Psychopharmacologia (Berl.) 45, 21–28 (1975)
Papeschi, R., Munkvad, I.: Relation of the effect of neuroleptics in animals to pharmacological parkinsonism and antipsychotic action in man. In: Psychopharmacology, sexual disorders and drug abuse, pp. 415–429. Amsterdam and London: North-Holland 1973
Papeschi, R., Randrup, A.: Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors. Pharmakopsychiatr. Neuropsychopharmakol. 6, 137–157 (1973)
Papeschi, R., Randrup, A., Munkvad, I.: Effect of ECT on dopaminergic and noradrenergic mechanisms. II. Effect on dopamine and noradrenaline concentrations and turnovers. Psychopharmacologia (Berl.) 35, 159–168 (1974)
Papeschi, R., Theiss, P., Herz, A.: Effects of morphine on the turnover of brain catecholamines and serotonin in rats. Acute morphine administration. Eur. J. Pharmacol. 34, 253–261 (1975)
Randrup, A., Munkvad, I.: Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamine. In: Int. Symp. Amphetamines and Related Compounds, E. Costa and S. Garattini, eds., pp. 695–713. New York: Raven Press 1970
Reinhold, K., Bläsig, J., Herz, A.: Changes in brain concentration of biogenic amines and the antinociceptive effect of morphine in rats. Naunyn Schmiedebergs Arch. Pharmacol. 278, 69–80 (1973)
Roth, R. H., Stone, E. A.: The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue. Biochem. Pharmacol. 17, 1581–1590 (1968)
Sedvall, G. C., Weise, V. K., Kopin, I.: The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity. J. Pharmacol. Exp. Ther. 159, 274–282 (1968)
Stein, L.: Self-stimulation of the brain and the central stimulant action of amphetamines. Fed. Proc. 23, 836–850 (1964)
Stinus, L., Le Moal, M., Cardo, B.: Autostimulation et catecholamines. I. Intervention possible des deux «compartiments» (compartiment fonctionnel et compartiment de reserve). Physiol. Behav. 9, 175–182 (1972)
Stinus L., Thierry, A. M.: Self-stimulation and catecholamines. II. Blockade of self-stimulation by treatment with alpha-methylparatyrosine and the reinstatement by catecholamine precursor administration. Brain Res. 64, 189–198 (1973)
Theiss, P., Papeschi, R., Herz, A.: Effects of morphine on the turnover of brain catecholamines and serotonin in rats. Chronic morphine administration. Eur. J. Pharmacol. 34, 263–271 (1975)
Thierry, A. M., Blane, G., Glowinski, J.: Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons. Eur. J. Pharmacol. 14, 303–307 (1971)
Thierry, A. M., Blanc, G., Glowinski, J.: Further evidence for the heterogenous storage of noradrenaline in central noradrenergic terminals. Naunyn Schmiedebergs Arch. Pharmacol. 279, 255–266 (1973)
Thoa, N. B., Wooten, F. G., Axelrod, J., Kopin, I. J.: On the mechanism of release of norepinephrine from sympathetic nerves induced by depolarizing agents and sympathomimetic drugs. Mol. Pharmacol. 11, 10–18 (1975)
Weiner, N., Bjur, R.: The role of intraneuronal monoamine oxidase in the regulation of norepinephrine synthesis. In: Monoamine oxidases. New vistas, E. Costa and M. Sandler, eds., pp. 409–420, New York: Raven Press 1972
Weiner, N., Cloutier, G., Bjur, R., Pfeffer, R. I.: Modification of norepinephrine synthesis in intact tissue by drugs and during short-term adrenergic nerve stimulation. Pharmacol. Rev. 24, 203–221 (1972)
Weissman, A., Koe, B. K., Tenen, S. S.: Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 151, 339–352 (1966)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Papeschi, R. The functional pool of brain catecholamines: Its size and turnover rate. Psychopharmacology 55, 1–7 (1977). https://doi.org/10.1007/BF00432809
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432809